학술논문
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
09237534